$591 | SAVE $104 | Single User
$1186 | SAVE $209 | Global License

Physician Views: What future for wearable health technology?
[Published by FirstWord Pharma]

Published by FirstWord Pharma: 24 Apr 2014 | 116 | In Stock

Introduction

Scope



As the patient becomes a more proactive stakeholder in the healthcare sphere and the development of many treatment regimens becomes increasingly personalised, the role of wearable health technology is on the rise.


Such technologies are seen by many – from patient groups to pharma companies – as an inevitable evolution in the way patients are able to monitor their own health and obtain advice and guidance about healthier lifestyles and treatment options.


Wearable technology holds the promise as being a critical enabler in opening up the conversations and interactions between patients and physicians, potentially giving the latter a greater opportunity to prioritise treatment over diagnosis. By allowing patients to more accurately self monitor, wearable health technology could drive a seismic 'consumer revolution' argue experts.


Such a shift could prove significant if it has the potential to free up scarce healthcare resources, reduce costs, improve patient compliance and ultimately drive an improvement on outcomes.


Nevertheless, while recent advances in mobile and wearable technology have opened up these possibilities, converting them to realistic opportunities is beset with challenges. The cost associated with an unproven approach is one factor to consider, as are issues of patient compliance and data accuracy.


Puchase Reasons


To better gauge how physicians perceive the opportunities associated with wearable health technology, FirstWord polled 166 cardiologists and endocrinologists based in the EU5 and US. Specifically we asked them...


  • How aware they are of wearable health technologies

  • What they perceive to be the key benefits

  • What concerns they have

  • What they believe to be the biggest priority in wearable health technology that needs to be addressed over the next 12 months

  • Which stakeholder they believe will play the most important role in driving broad usage of wearable health technology
  • Table of Contents
    for Physician Views: What future for wearable health technology? [Published by FirstWord Pharma]

    Additional Details

    Publisher

    FirstWord Pharma

    Publisher Information

    Reference

    116 |

    Report Format

    PDF

    FirstWord Pharma Reports

    Related Reports

    TitleDate PublishedPrice fromMore Details
    SAVE 15% today! Physician Views: Can the launch of ViiV Healthcare's dolutegravir disrupt Gilead's dominance in the HIV market?
    ScopeBased on current timelines, the FDA is poised to approve the HIV therapy dolutegravir later thi...
    01 Aug 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Will generic Copaxone have traction in the MS market given emergence of oral therapies?
    ScopeA recent ruling by the US Court of Appeals for the Federal Circuit has increased the likelihood...
    01 Aug 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
    ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
    01 Aug 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Post ADA view on key diabetes market developments
    ScopeLast week’s American Diabetes Association (ADA) meeting provided further evidence that the diab...
    01 Jul 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Biosimilar Remicade poised for approval in Europe – are rheumatologists and gastroenterologists ready?
    ScopeThe recent recommendation to approve a biosimilar version of Merck & Co./Johnson & Johnson's Re...
    01 Jul 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Do EU pulmonologists anticipate rapid uptake for GSK’s Seretide-successor?
    ScopeAs GlaxoSmithKline's Relvar Ellipta – a once-daily successor to its multi-billion dollar Sereti...
    01 Jul 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Key developments in the European diabetes market - will endocrinologists embrace Tresiba and Forxiga? – both rejected by the FDA
    ScopeEuropean-based endocrinologists are currently getting to grips with two new products that have ...
    01 Jul 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Recent developments in US diabetes market – impact of safety concerns & emergence of SGLT-2 drug class
    ScopeWith the diabetes market an important therapeutic area for a host of pharmaceutical manufacture...
    01 Jun 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Physician Views: Life after Gleevec in the chronic myeloid leukaemia (CML) market?
    ScopeNovartis' Gleevec is widely credited as being one of the most important drug launches of all ti...
    01 Jun 2013 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info
    SAVE 15% today! Surveying Physician Uptake of Mobile Devices and Apps
    IntroductionThe latest medical application software is increasing physicians’ use of mobile technolo...
    01 Oct 2012 by FirstWord Pharma USD $591 (normally
    USD $695)
    More Info

    This report is published by FirstWord Pharma

    Download Free Report Summary PDF

    Physician Views: What future for wearable health technology? [Published by FirstWord Pharma] | Download PDF Summary

    Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

    Ordering Information

    Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

    Accepted Card Types

    Payment

    Buy now using our secure payment system.

    We Stock...